Your browser doesn't support javascript.
loading
Radiation treatment of benign tumors in NF2-related-schwannomatosis: A national study of 266 irradiated patients showing a significant increase in malignancy/malignant progression.
Evans, D Gareth; Halliday, Dorothy; Obholzer, Rupert; Afridi, Shazia; Forde, Claire; Rutherford, Scott A; Hammerbeck-Ward, Charlotte; Lloyd, Simon K; Freeman, Simon M; Pathmanaban, Omar N; Thomas, Owen M; Laitt, Roger D; Stivaros, Stavros; Kilday, John-Paul; Vassallo, Grace; McBain, Catherine; Lavin, Timothy; Paterson, Chay; Whitfield, Gillian; McCabe, Martin G; Axon, Patrick R; Halliday, Jane; Mackeith, Samuel; Parry, Allyson; Harkness, Elaine F; Buttimore, Juliette; King, Andrew T.
Afiliação
  • Evans DG; Division of Evolution and Genomic Medicine, Manchester Centre for Genomic Medicine, Manchester Academic Health Science Centre, University of Manchester, St Mary's Hospital, Manchester Universities NHS Foundation Trust, Manchester, UK.
  • Halliday D; Geoffrey Jefferson Brain Research Centre, Manchester Academic Health Science Centre, Northern Care Alliance NHS Foundation Trust, University of Manchester, UK.
  • Obholzer R; Departments of Genomic Medicine, Neurology, Neurosurgery, ENT, Oxford University Hospitals NHS Foundation Trust.
  • Afridi S; Department of ENT, and Neurology, London, UK.
  • Forde C; Guy's and St Thomas' NHS Trust, London, UK.
  • Rutherford SA; Division of Evolution and Genomic Medicine, Manchester Centre for Genomic Medicine, Manchester Academic Health Science Centre, University of Manchester, St Mary's Hospital, Manchester Universities NHS Foundation Trust, Manchester, UK.
  • Hammerbeck-Ward C; Departments of Neurosurgery, Otolaryngology, Neuroradiology, and Neurology, Manchester Centre for Clinical Neurosciences Salford Royal Hospital, Northern Care Alliance NHS Foundation Trust, Manchester, UK.
  • Lloyd SK; Departments of Neurosurgery, Otolaryngology, Neuroradiology, and Neurology, Manchester Centre for Clinical Neurosciences Salford Royal Hospital, Northern Care Alliance NHS Foundation Trust, Manchester, UK.
  • Freeman SM; Departments of Neurosurgery, Otolaryngology, Neuroradiology, and Neurology, Manchester Centre for Clinical Neurosciences Salford Royal Hospital, Northern Care Alliance NHS Foundation Trust, Manchester, UK.
  • Pathmanaban ON; Departments of Neurosurgery, Otolaryngology, Neuroradiology, and Neurology, Manchester Centre for Clinical Neurosciences Salford Royal Hospital, Northern Care Alliance NHS Foundation Trust, Manchester, UK.
  • Thomas OM; Departments of Neurosurgery, Otolaryngology, Neuroradiology, and Neurology, Manchester Centre for Clinical Neurosciences Salford Royal Hospital, Northern Care Alliance NHS Foundation Trust, Manchester, UK.
  • Laitt RD; Division of Neuroscience and Experimental Psychology, Faculty of Biology, Medicine and Health, University of Manchester, UK.
  • Stivaros S; Geoffrey Jefferson Brain Research Centre, Manchester Academic Health Science Centre, Northern Care Alliance NHS Foundation Trust, University of Manchester, UK.
  • Kilday JP; Departments of Neurosurgery, Otolaryngology, Neuroradiology, and Neurology, Manchester Centre for Clinical Neurosciences Salford Royal Hospital, Northern Care Alliance NHS Foundation Trust, Manchester, UK.
  • Vassallo G; Departments of Neurosurgery, Otolaryngology, Neuroradiology, and Neurology, Manchester Centre for Clinical Neurosciences Salford Royal Hospital, Northern Care Alliance NHS Foundation Trust, Manchester, UK.
  • McBain C; Division of Informatics, Imaging and Data Sciences, School of Health Sciences, Faculty of Biology, Medicine and Health, The University of Manchester, Manchester Academic Health Science Centre, Oxford Road, Manchester, M13 9PL, UK.
  • Lavin T; Academic Unit of Paediatric Radiology, Royal Manchester Children's Hospital, Central Manchester University Hospitals NHS Foundation Trust, Manchester Academic Health Science Centre, Manchester, UK.
  • Paterson C; Geoffrey Jefferson Brain Research Centre, Manchester Academic Health Science Centre, Northern Care Alliance NHS Foundation Trust, University of Manchester, UK.
  • Whitfield G; Children's Brain Tumour Research Network (CBTRN), Royal Manchester Children's Hospital, Manchester, UK.
  • McCabe MG; Division of Cancer Sciences, Faculty of Biology, Medicine and Health, University of Manchester, UK.
  • Axon PR; Division of Evolution and Genomic Medicine, Manchester Centre for Genomic Medicine, Manchester Academic Health Science Centre, University of Manchester, St Mary's Hospital, Manchester Universities NHS Foundation Trust, Manchester, UK.
  • Halliday J; The Christie NHS Foundation Trust, Manchester, UK.
  • Mackeith S; Geoffrey Jefferson Brain Research Centre, Manchester Academic Health Science Centre, Northern Care Alliance NHS Foundation Trust, University of Manchester, UK.
  • Parry A; Departments of Neurosurgery, Otolaryngology, Neuroradiology, and Neurology, Manchester Centre for Clinical Neurosciences Salford Royal Hospital, Northern Care Alliance NHS Foundation Trust, Manchester, UK.
  • Harkness EF; Children's Brain Tumour Research Network (CBTRN), Royal Manchester Children's Hospital, Manchester, UK.
  • Buttimore J; Division of Cancer Sciences, Faculty of Biology, Medicine and Health, University of Manchester, UK.
  • King AT; The Christie NHS Foundation Trust, Manchester, UK.
Neurooncol Adv ; 5(1): vdad025, 2023.
Article em En | MEDLINE | ID: mdl-37051330
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Idioma: En Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Reino Unido
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Idioma: En Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Reino Unido